Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$10.56 -0.70 (-6.22%)
As of: Oct 2, 2026 · 3:40 PM EDT

Monte Rosa Therapeutics (GLUE) Return on Assets [ROA] (2021 - 2026)

Updated

Monte Rosa Therapeutics (GLUE) reported Return on Assets [ROA] of -22.58% for Q2 2026, down 29.00 percentage points from 6.42% a year earlier and down 0.63 percentage points from the prior quarter.

Analysis

Monte Rosa Therapeutics (GLUE) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Monte Rosa Therapeutics posted Return on Assets [ROA] of -8.71%, up 10.88 percentage points from FY2024.

  • Return on Assets [ROA] has a four-year change of +26.36 percentage points (FY2021 to FY2025).
  • By year, Return on Assets [ROA] came in at -19.58% in FY2024 (+22.31 pp), -41.90% in FY2023 (-11.28 pp), -30.62% in FY2022 (+4.45 pp) and -35.06% in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Return on Assets [ROA] since Q3 2024.
  • Year over year, Return on Assets [ROA] gained in six of the last eight quarters, with an average year-over-year change of +17.62 percentage points.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q2 2025 (a gain of 49.13 percentage points); the low point was Q2 2026 (a drop of 29.00 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -21.95% (Q1 2026), -8.50% (Q4 2025) and 5.11% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Monte Rosa Therapeutics 1.02 Bn 428.56 Mn - -22.58%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -22.58%
Mar 31, 2026 -21.95%
Dec 31, 2025 -8.50%
Sep 30, 2025 5.11%
Jun 30, 2025 6.42%
Mar 31, 2025 1.48%
Dec 31, 2024 -19.29%
Sep 30, 2024 -36.23%
Jun 30, 2024 -42.70%
Mar 31, 2024 -47.43%
Dec 31, 2023 -48.70%
Sep 30, 2023 -50.08%
Jun 30, 2023 -42.65%
Mar 31, 2023 -35.80%
Dec 31, 2022 -31.11%
Sep 30, 2022 -28.08%
Jun 30, 2022 -26.45%
Mar 31, 2022 -24.06%
Dec 31, 2021 -19.43%
Sep 30, 2021 -16.32%
API Access

Monte Rosa Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GLUE&period=max&api_key=YOUR_API_KEY